Basit öğe kaydını göster

Clinical Outcomes Related to the Use of Bendamustine Therapy for Multiple Myeloma Patients Relapsed/Refractory to Immunomodulatory Drugs and Proteasome Inhibitors

dc.contributor.authorEskazan, A. Emre
dc.contributor.authorAr, M. Cem
dc.contributor.authorAydin, Yildiz
dc.contributor.authorSoysal, Teoman
dc.contributor.authorSalihoglu, Ayse
dc.contributor.authorOngoren, Seniz
dc.contributor.authorYalniz, Fevzi Firat
dc.contributor.authorAkkoc, Nihan
dc.date.accessioned2021-03-05T09:14:14Z
dc.date.available2021-03-05T09:14:14Z
dc.date.issued2017
dc.identifier.citationYalniz F. F. , Akkoc N., Salihoglu A., Ar M. C. , Ongoren S., Eskazan A. E. , Soysal T., Aydin Y., "Clinical Outcomes Related to the Use of Bendamustine Therapy for Multiple Myeloma Patients Relapsed/Refractory to Immunomodulatory Drugs and Proteasome Inhibitors", TURKISH JOURNAL OF HEMATOLOGY, cilt.34, ss.233-238, 2017
dc.identifier.issn1300-7777
dc.identifier.othervv_1032021
dc.identifier.otherav_9cf0439a-ee91-456b-b143-b2af3f324207
dc.identifier.urihttp://hdl.handle.net/20.500.12627/105441
dc.identifier.urihttps://doi.org/10.4274/tjh.2016.0397
dc.description.abstractObjective: Multiple myeloma patients who are relapsed or refractory to both proteasome inhibitors (PIs) and immunomodulatory drugs (IMiDs) have been reported to have poor outcomes. Bendamustine has been reported to have an antitumor effect in newly diagnosed as well as relapsed/refractory multiple myeloma (RRMM). The aim of this retrospective study was to evaluate the efficacy of bendamustine therapy in heavily pretreated MM patients who were refractory to PIs and IMiDs.
dc.language.isoeng
dc.subjectİç Hastalıkları
dc.subjectHEMATOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectHematoloji
dc.titleClinical Outcomes Related to the Use of Bendamustine Therapy for Multiple Myeloma Patients Relapsed/Refractory to Immunomodulatory Drugs and Proteasome Inhibitors
dc.typeMakale
dc.relation.journalTURKISH JOURNAL OF HEMATOLOGY
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume34
dc.identifier.issue3
dc.identifier.startpage233
dc.identifier.endpage238
dc.contributor.firstauthorID245197


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster